14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $14.00 $25.47 Thursday, 2nd May 2024 DCPH stock ended at $25.38. This is 0.0789% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 0.493% from a day low at $25.35 to a day high of $25.47.
90 days $13.86 $25.47
52 weeks $9.90 $25.47

Historical Deciphera Pharmaceuticals Inc prices

Date Open High Low Close Volume
Jan 16, 2024 $14.59 $14.65 $14.34 $14.46 549 511
Jan 12, 2024 $15.15 $15.32 $14.66 $14.84 346 993
Jan 11, 2024 $15.11 $15.29 $14.65 $14.90 535 743
Jan 10, 2024 $15.46 $15.87 $15.12 $15.29 391 956
Jan 09, 2024 $15.51 $15.71 $15.25 $15.49 328 989
Jan 08, 2024 $15.44 $15.97 $15.02 $15.70 430 314
Jan 05, 2024 $15.80 $15.80 $15.12 $15.29 370 556
Jan 04, 2024 $16.04 $16.58 $15.59 $15.85 298 340
Jan 03, 2024 $16.53 $16.63 $15.90 $15.99 286 457
Jan 02, 2024 $15.98 $17.07 $15.82 $16.55 484 930
Dec 29, 2023 $16.36 $16.43 $16.08 $16.13 413 731
Dec 28, 2023 $16.09 $16.44 $15.86 $16.43 321 548
Dec 27, 2023 $16.55 $16.56 $15.91 $16.05 358 162
Dec 26, 2023 $16.56 $16.69 $16.38 $16.54 348 712
Dec 22, 2023 $15.68 $16.54 $15.68 $16.37 533 379
Dec 21, 2023 $15.33 $15.58 $15.11 $15.54 541 272
Dec 20, 2023 $15.61 $15.69 $15.11 $15.14 457 947
Dec 19, 2023 $15.96 $16.31 $15.63 $15.70 339 732
Dec 18, 2023 $15.85 $15.99 $15.56 $15.86 449 516
Dec 15, 2023 $16.06 $16.26 $15.74 $15.95 924 550
Dec 14, 2023 $16.21 $16.50 $15.80 $15.83 541 232
Dec 13, 2023 $15.35 $16.10 $15.18 $16.03 619 620
Dec 12, 2023 $15.40 $15.45 $14.83 $15.28 488 047
Dec 11, 2023 $14.81 $15.35 $14.39 $15.29 747 446
Dec 08, 2023 $15.01 $15.46 $14.78 $14.80 959 630
Click to get the best stock tips daily for free!

About Deciphera Pharmaceuticals Inc

Deciphera Pharmaceuticals Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. Th... DCPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT